Severe Acute Respiratory Syndrome–Coronavirus-2 Infection and Patients With Lung Cancer: The Potential Role of Interleukin-17 Target Therapy

The coronavirus disease 2019 outbreak is evolving rapidly worldwide. The lungs are the target of the primary infection and patients with lung cancer seem to have a poor prognosis. To our knowledge, this is the first reported investigation of a possible role of interleukin-17 target therapy in patien...

Descripción completa

Detalles Bibliográficos
Autor principal: Cafarotti, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Association for the Study of Lung Cancer. Published by Elsevier Inc. 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185017/
https://www.ncbi.nlm.nih.gov/pubmed/32353597
http://dx.doi.org/10.1016/j.jtho.2020.04.015
Descripción
Sumario:The coronavirus disease 2019 outbreak is evolving rapidly worldwide. The lungs are the target of the primary infection and patients with lung cancer seem to have a poor prognosis. To our knowledge, this is the first reported investigation of a possible role of interleukin-17 target therapy in patients with lung cancer and concomitant severe acute respiratory syndrome–coronavirus-2 infection.

Ejemplares similares